secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001174947-25-000809
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRIDEX receives Nasdaq delisting notice; equity only $852K vs $2.5M minimum; seeks shareholder vote
--------------------------------------------------------------------------------

- Stockholders' equity was ~$852,000 as of March 29, 2025, below Nasdaq's $2.5M minimum.
- Company to seek shareholder approval at June 11, 2025 annual meeting to reclassify Series B Preferred Stock as permanent equity.
- If approved, $6M Series B sale would reclassify, potentially bringing equity above minimum.
- Must submit compliance plan to Nasdaq by June 30, 2025; may receive up to 180-day cure period if plan accepted.
- No immediate impact on Nasdaq listing or business operations, but delisting risk remains if plan fails.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000117494725000809/0001174947-25-000809-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000117494725000809/ea021696306-8k_iridex.htm
  HTML page:      https://secwatch.observer/filing/0001174947-25-000809

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer